Implementation of corticosteroids in treating COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective observational cohort study

Implementation of corticosteroids into clinical practice in the UK for patients with COVID-19 has been successful, but not universal. Patients over 70 years of age, independent of illness severity, chronic neurological disease and dementia, were less likely to receive corticosteroids, as were pregnant women. This could reflect appropriate clinical decision making, but the possibility of inequitable access to life-saving care should be considered.


Comments are closed